RE: Smoke and mirrors21 Nov 2020 09:48
greggstottie
Diagnostic companies in the past were always the poor relation in the healthcare sector.In other words the ground crew
Biotechs were the fighter pilots with pharmas being the bombers. Pardon the analgy.
In financial terms the registrar as compared to the stockbroker.
Hopefully diagnostics will become the new biotechs in terms of valuation, but i am sure some wealth managers will find it difficult to adjust to that.